CTRI/2020/10/028371已完成4 期
A prospective, randomized, open label, clinical study to evaluate safety and effectiveness of novel methylcobalamin nasal spray compared to oral methylcobalamin in the treatment of subjects with vitamin B12 deficiency.
Dr Sudhir Kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1) Vitamin B12 level < 200 pg/mL (148 pmol/L)
- •2) Above the age of 18 years
- •3) Willing & able to comply with study requirements, e.g. usage of medicines as per protocol, willing to adhere with study visit schedule and willing to fill Patient Diary, as indicated by written informed consent provided by the patient.
- •4) Study population will be EITHER any of the following in either gender:
- •a) General Population
- •b) Patients who are on Metformin (ââ?°Â¥1000mg/day) therapy for ââ?°Â¥ 4 months
- •c) Anaemic patients having hemoglobin level of < 9 g/dL
- •d) Chronic Alcoholic Patients as per DSM V criteria
- •e) Patients on PPI therapy for ââ?°Â¥ 6 months
- •f) Patients who have undergone Bariatric Surgery (e.g. RYGB surgery/ Mini gastric bypass surgery/ Sleeve Gastrectomy/ Sleeve Gastroplasty etc) OR Gastric Surgery for any indication.
- •OR Study population will be any of the following in female population:
- •g) Women on Oral Contraceptive Pills
- •h) Women with Poly Cystic Ovarian Disease(PCOD) on Metformin
- •5) If women of childbearing potential are recruited they must be non-pregnant (supported by negative urine pregnancy test at screening), and be willing to maintain reliable birth control throughout the study.
排除标准
- •1) Lactating Women
- •2) Patients with known hypersensitivity or allergies to cobalt and/or vitamin B12 or any component of the study medication.
- •3) Patients with any significant nasal pathology, or having chronic nasal symptoms or nasal allergies or upper respiratory tract infections.
- •4) Patient using any other nasal medication/device.
- •5) Patients having a known diagnosis of severe renal impairment or renal failure. Patients on treatment with drugs which interfere with vitamin B12 assay.
- •6) Participated in any clinical trial within last 30 days at the time of screening.
- •7) Any disorder or condition that in the opinion of investigator would prohibit study participation or affect study outcome.
研究者
相似试验
尚未招募
4 期
to compare the effectiveness of Methylcobalamin Nasal Spray and Oral Methylcobalamin tablet in B12 deficient patients.CTRI/2020/03/023938Dr Arunansu Talukdar
尚未招募
4 期
To check the effectiveness and safety of Methylcobalamin nasal spray in comparison with oral methylcobalamin tablet and methylcobalamin injection.CTRI/2020/08/027422Dr Dushyant Balat
已完成
4 期
A clinical study to evaluate the effect of Methylcobalamine nasal spray in patients with subclinical cobalamin deficiency.CTRI/2020/10/028370Dr Sudhir Kumar
已完成
4 期
Study to compare the efficacy and safety of novel Methylcobalamin Spray with Sublingual Methylcobalamin Tablet in treatment of subjects with vitamin B12 deficiency.CTRI/2024/04/066019Troikaa Pharmaceuticals Limited37
已完成
不适用
Clinical study on low calorie Mulmina D Mango in Diabetes PatientsCTRI/2021/07/034675Jagdale HealthCare100